Niels Van De Donk

This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Janssen Biotech, Inc., Stichting Vumc. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niels Van De Donk. Retrieved from https://idiyas.com/inventor/niels-van-de-donk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 25(Granted Patents)

Location History:

Amsterdam, NL (2020)
De Boelelaan, NL (2021)
De Boelalaan, NL (2024)

Company Filing History:

4 out of 433

Janssen Biotech, Inc.

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065500 - Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics (2024-08-20),

2. 12012461 - Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics (2024-06-18),

3. 11021543 - Immune modulation and treatment of solid tumors with antibodies that specifically bind CD38 (2021-06-01),

4. 10604580 - Combination therapies with anti-CD38 antibodies (2020-03-31),

Title: Niels Van De Donk: Innovator in Cancer Treatment

Introduction

Niels Van De Donk is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of four patents to his name, he is recognized for his dedication to enhancing therapeutic approaches in oncology.

Latest Patents

Niels Van De Donk's latest patents focus on methods of treating cancers and enhancing the efficacy of T cell redirecting therapeutics. These patents disclose novel techniques aimed at improving treatment outcomes for cancer patients. His work in this area is crucial for advancing therapeutic strategies and providing new hope for those affected by cancer.

Career Highlights

Throughout his career, Niels has worked with notable organizations, including Janssen Biotech, Inc. and Stichting Vumc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Niels has collaborated with esteemed colleagues such as Henk Lokhorst and Tuna Mutis. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the pursuit of effective cancer treatments.

Conclusion

Niels Van De Donk is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic methods. His contributions to the field are invaluable and continue to inspire advancements in oncology.

Profile summary based on public USPTO records.